United States · Biotechnology startup

Stemcentrx

Stemcentrx provides pharmaceutical services.

Funding reportedLast round: Series G

BiotechnologySouth San Francisco, United States

What company datasets say Stemcentrx raised

Funding, as reported

Reported in all$516Min dollars
Rounds4
Last roundSeries G
Last round dateSept 2015
Investors listed8
SEC Form D$24M sold, 1 filing, last Mar 2011

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Stemcentrx in front of investors. Or tell us what we have wrong.